Please wait while the formulary information is being retrieved.
Drug overview for MULTIHANCE MULTIPACK (gadobenate dimeglumine):
Generic name: GADOBENATE DIMEGLUMINE
Drug class:
Therapeutic class: Diagnostic Agents
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
Generic name: GADOBENATE DIMEGLUMINE
Drug class:
Therapeutic class: Diagnostic Agents
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
DRUG IMAGES
MULTIHANCE 529 MG/ML VIAL
The following indications for MULTIHANCE MULTIPACK (gadobenate dimeglumine) have been approved by the FDA:
Indications:
Diagnostic imaging
Professional Synonyms:
Diagnostic imaging exam
Diagnostic imaging procedure
Diagnostic radiography
Diagnostic radiology
Indications:
Diagnostic imaging
Professional Synonyms:
Diagnostic imaging exam
Diagnostic imaging procedure
Diagnostic radiography
Diagnostic radiology
The following dosing information is available for MULTIHANCE MULTIPACK (gadobenate dimeglumine):
No enhanced Dosing information available for this drug.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for MULTIHANCE MULTIPACK (gadobenate dimeglumine):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for MULTIHANCE MULTIPACK (gadobenate dimeglumine):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 3 contraindications.
Absolute contraindication.
| Contraindication List |
|---|
| Acute renal failure |
| Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min |
| Nephrogenic systemic fibrosis |
There are 2 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Congenital long QT syndrome |
| Kidney disease with likely reduction in glomerular filtration rate (GFr) |
There are 3 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Asthma |
| Cardiac arrhythmia |
| Disease of liver |
The following adverse reaction information is available for MULTIHANCE MULTIPACK (gadobenate dimeglumine):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 12 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. | None. |
| Rare/Very Rare |
|---|
|
Acute pancreatitis Acute respiratory distress syndrome Anaphylaxis Dyspnea Extravasation injury Facial edema Hypersensitivity drug reaction Nephrogenic systemic fibrosis Paresthesia Pulmonary edema Seizure disorder Tongue swelling |
There are 32 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. |
Headache disorder Nausea |
| Rare/Very Rare |
|---|
|
Abdominal pain with cramps Cardiac arrhythmia Chest pain Chills Diarrhea Dizziness Dysgeusia Fatigue General weakness Hyperhidrosis Hypertension Injection site sequelae Laryngismus Malaise Myalgia Nasal congestion Ocular inflammation Ocular itching Pain Parosmia Pruritus of skin Skin plaque Skin rash Tinnitus Tremor Urticaria Visual changes Vomiting Wheezing Xerostomia |
The following precautions are available for MULTIHANCE MULTIPACK (gadobenate dimeglumine):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for MULTIHANCE MULTIPACK (gadobenate dimeglumine):
WARNING: This medication may rarely cause kidney damage. The risk of kidney damage is greater if you already have kidney problems, if you are an older adult, or if you have high blood pressure or diabetes. Your doctor should check how well your kidneys are working before you receive this medication. See also Side Effects section.
WARNING: This medication may rarely cause kidney damage. The risk of kidney damage is greater if you already have kidney problems, if you are an older adult, or if you have high blood pressure or diabetes. Your doctor should check how well your kidneys are working before you receive this medication. See also Side Effects section.
The following icd codes are available for MULTIHANCE MULTIPACK (gadobenate dimeglumine)'s list of indications:
No ICD codes found for this drug.
No ICD codes found for this drug.
Formulary Reference Tool